Anderson-Fabry's disease

Neuropathological and neurochemical investigation

F. Tagliavini, V. Pietrini, F. Gemignani, A. Lechi, A. Pallini, A. Federico

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

A clinical, neuropathological and neurochemical study of a case of Anderson-Fabry's disease is described. The clinical course mainly consisted of repeated icuts with major involvement of the CNS. The neuropathological examination is dominated by severe alterations in the cerebral vessels due to glycolipid deposits on the walls, with reduction or occlusion of the lumen. This is correlated with secondary ischaemic foci scattered throughout the cortex as well as through the white matter. In addition, the cells of the cerebral cortex, thalamus, basal ganglia, amygdala, cerebellar and olivary nuclei show a marked accumulation of lipofuscin. Biochemical examination reveals a threefold increase in galactolipids due to the specific α-galactosidase deficiency. Cholesterol is reduced secondarily to ischaemic myelin damage. Glycosaminoglycans uronic acid is increased in cytosol and membrane-bound fractions which could be related to reactive gliosis. Glycoprotein sugars show a decrease in N-acetyl-neuraminic acid and fucose as well as an increase in hexosamines and hexoses in membrane-bound fraction, while in cytosol fraction all sugars are increased. This suggests that the α-galactosidase deficiency can alter not only the glycolipid but also the glycoprotein metabolism, resulting in a higher presence of hexosamines and hexoses-rich glycoproteins.

Original languageEnglish
Pages (from-to)93-98
Number of pages6
JournalActa Neuropathologica
Volume56
Issue number2
DOIs
Publication statusPublished - Jun 1982

Fingerprint

Fabry Disease
Galactosidases
Hexosamines
Glycoproteins
Hexoses
Glycolipids
Basal Ganglia
Cytosol
Galactolipids
Neuraminic Acids
Olivary Nucleus
Uronic Acids
Lipofuscin
Cerebellar Nuclei
Gliosis
Fucose
Membranes
Myelin Sheath
Glycosaminoglycans
Amygdala

Keywords

  • Anderson-Fabry's disease
  • Neurochemistry
  • Neuropathology

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pathology and Forensic Medicine
  • Clinical Neurology

Cite this

Tagliavini, F., Pietrini, V., Gemignani, F., Lechi, A., Pallini, A., & Federico, A. (1982). Anderson-Fabry's disease: Neuropathological and neurochemical investigation. Acta Neuropathologica, 56(2), 93-98. https://doi.org/10.1007/BF00690579

Anderson-Fabry's disease : Neuropathological and neurochemical investigation. / Tagliavini, F.; Pietrini, V.; Gemignani, F.; Lechi, A.; Pallini, A.; Federico, A.

In: Acta Neuropathologica, Vol. 56, No. 2, 06.1982, p. 93-98.

Research output: Contribution to journalArticle

Tagliavini, F, Pietrini, V, Gemignani, F, Lechi, A, Pallini, A & Federico, A 1982, 'Anderson-Fabry's disease: Neuropathological and neurochemical investigation', Acta Neuropathologica, vol. 56, no. 2, pp. 93-98. https://doi.org/10.1007/BF00690579
Tagliavini, F. ; Pietrini, V. ; Gemignani, F. ; Lechi, A. ; Pallini, A. ; Federico, A. / Anderson-Fabry's disease : Neuropathological and neurochemical investigation. In: Acta Neuropathologica. 1982 ; Vol. 56, No. 2. pp. 93-98.
@article{6addcc73d3194349bd98dd45c0777260,
title = "Anderson-Fabry's disease: Neuropathological and neurochemical investigation",
abstract = "A clinical, neuropathological and neurochemical study of a case of Anderson-Fabry's disease is described. The clinical course mainly consisted of repeated icuts with major involvement of the CNS. The neuropathological examination is dominated by severe alterations in the cerebral vessels due to glycolipid deposits on the walls, with reduction or occlusion of the lumen. This is correlated with secondary ischaemic foci scattered throughout the cortex as well as through the white matter. In addition, the cells of the cerebral cortex, thalamus, basal ganglia, amygdala, cerebellar and olivary nuclei show a marked accumulation of lipofuscin. Biochemical examination reveals a threefold increase in galactolipids due to the specific α-galactosidase deficiency. Cholesterol is reduced secondarily to ischaemic myelin damage. Glycosaminoglycans uronic acid is increased in cytosol and membrane-bound fractions which could be related to reactive gliosis. Glycoprotein sugars show a decrease in N-acetyl-neuraminic acid and fucose as well as an increase in hexosamines and hexoses in membrane-bound fraction, while in cytosol fraction all sugars are increased. This suggests that the α-galactosidase deficiency can alter not only the glycolipid but also the glycoprotein metabolism, resulting in a higher presence of hexosamines and hexoses-rich glycoproteins.",
keywords = "Anderson-Fabry's disease, Neurochemistry, Neuropathology",
author = "F. Tagliavini and V. Pietrini and F. Gemignani and A. Lechi and A. Pallini and A. Federico",
year = "1982",
month = "6",
doi = "10.1007/BF00690579",
language = "English",
volume = "56",
pages = "93--98",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Anderson-Fabry's disease

T2 - Neuropathological and neurochemical investigation

AU - Tagliavini, F.

AU - Pietrini, V.

AU - Gemignani, F.

AU - Lechi, A.

AU - Pallini, A.

AU - Federico, A.

PY - 1982/6

Y1 - 1982/6

N2 - A clinical, neuropathological and neurochemical study of a case of Anderson-Fabry's disease is described. The clinical course mainly consisted of repeated icuts with major involvement of the CNS. The neuropathological examination is dominated by severe alterations in the cerebral vessels due to glycolipid deposits on the walls, with reduction or occlusion of the lumen. This is correlated with secondary ischaemic foci scattered throughout the cortex as well as through the white matter. In addition, the cells of the cerebral cortex, thalamus, basal ganglia, amygdala, cerebellar and olivary nuclei show a marked accumulation of lipofuscin. Biochemical examination reveals a threefold increase in galactolipids due to the specific α-galactosidase deficiency. Cholesterol is reduced secondarily to ischaemic myelin damage. Glycosaminoglycans uronic acid is increased in cytosol and membrane-bound fractions which could be related to reactive gliosis. Glycoprotein sugars show a decrease in N-acetyl-neuraminic acid and fucose as well as an increase in hexosamines and hexoses in membrane-bound fraction, while in cytosol fraction all sugars are increased. This suggests that the α-galactosidase deficiency can alter not only the glycolipid but also the glycoprotein metabolism, resulting in a higher presence of hexosamines and hexoses-rich glycoproteins.

AB - A clinical, neuropathological and neurochemical study of a case of Anderson-Fabry's disease is described. The clinical course mainly consisted of repeated icuts with major involvement of the CNS. The neuropathological examination is dominated by severe alterations in the cerebral vessels due to glycolipid deposits on the walls, with reduction or occlusion of the lumen. This is correlated with secondary ischaemic foci scattered throughout the cortex as well as through the white matter. In addition, the cells of the cerebral cortex, thalamus, basal ganglia, amygdala, cerebellar and olivary nuclei show a marked accumulation of lipofuscin. Biochemical examination reveals a threefold increase in galactolipids due to the specific α-galactosidase deficiency. Cholesterol is reduced secondarily to ischaemic myelin damage. Glycosaminoglycans uronic acid is increased in cytosol and membrane-bound fractions which could be related to reactive gliosis. Glycoprotein sugars show a decrease in N-acetyl-neuraminic acid and fucose as well as an increase in hexosamines and hexoses in membrane-bound fraction, while in cytosol fraction all sugars are increased. This suggests that the α-galactosidase deficiency can alter not only the glycolipid but also the glycoprotein metabolism, resulting in a higher presence of hexosamines and hexoses-rich glycoproteins.

KW - Anderson-Fabry's disease

KW - Neurochemistry

KW - Neuropathology

UR - http://www.scopus.com/inward/record.url?scp=0020041916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020041916&partnerID=8YFLogxK

U2 - 10.1007/BF00690579

DO - 10.1007/BF00690579

M3 - Article

VL - 56

SP - 93

EP - 98

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 2

ER -